Flickdox O is a combination medication that contains 200 mg of cefpodoxime proxetil and 200 mg of ofloxacin per tablet. This formulation is specifically designed to combat a range of bacterial infections effectively. Cefpodoxime proxetil is a broad-spectrum cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, thus stopping the growth of bacteria. Ofloxacin, a fluoroquinolone antibiotic, acts by interfering with bacterial DNA replication and repair processes, further enhancing the therapeutic efficacy of the treatment.
Flickdox O is indicated for the treatment of various infections, including respiratory tract infections, urinary tract infections, and skin infections caused by susceptible bacteria. Its dual-action mechanism offers a synergistic effect, making it a preferred choice for healthcare professionals when dealing with polymicrobial infections.
Patients should be aware of potential side effects, which may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain. Other possible side effects include dizziness, headache, and allergic reactions in some individuals. It is essential for patients to consult with their healthcare provider if they experience severe or persistent symptoms.
For optimal storage, keep Flickdox O tablets in a cool, dry place away from direct sunlight and moisture. Ensure that the medication is out of reach of children to prevent accidental ingestion.